Skip to content

Safety of ENC-201-CED ENCRT

Diabetes Mellitus, Type 1

The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 to 70

Critères de participation

Inclusion Criteria:

* Candidates must satisfy site's eligibility for standard of care islet infusion.

Exclusion Criteria:

* Candidates are excluded based on the site's criteria for standard of care islet infusion.

Lieu de l'étude

McGill University Health Centre
McGill University Health Centre
Montréal, Quebec
Canada

Contactez l'équipe d'étude

McGill University Health Centre
McGill University Health Centre
Montreal, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Lin Jawhar

UHN
UHN
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Trial Coordinator, BSc

[email protected]
416-340-4800
Étude parrainée par
Encellin
Participants recherchés
Plus d'informations
ID de l'étude: NCT06408311